GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Apollomics Inc (NAS:APLMW) » Definitions » Long-Term Capital Lease Obligation

Apollomics (Apollomics) Long-Term Capital Lease Obligation : $0.27 Mil (As of Dec. 2023)


View and export this data going back to 2023. Start your Free Trial

What is Apollomics Long-Term Capital Lease Obligation?

Apollomics's Long-Term Capital Lease Obligation for the quarter that ended in Dec. 2023 was $0.27 Mil.

Apollomics's quarterly Long-Term Capital Lease Obligation declined from Dec. 2022 ($0.38 Mil) to Jun. 2023 ($0.29 Mil) and declined from Jun. 2023 ($0.29 Mil) to Dec. 2023 ($0.27 Mil).

Apollomics's annual Long-Term Capital Lease Obligation declined from Dec. 2021 ($0.53 Mil) to Dec. 2022 ($0.38 Mil) and declined from Dec. 2022 ($0.38 Mil) to Dec. 2023 ($0.27 Mil).

Apollomics Long-Term Capital Lease Obligation Historical Data

The historical data trend for Apollomics's Long-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Apollomics Long-Term Capital Lease Obligation Chart

Apollomics Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Long-Term Capital Lease Obligation
1.00 0.53 0.38 0.27

Apollomics Semi-Annual Data
Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Long-Term Capital Lease Obligation Get a 7-Day Free Trial 0.53 0.65 0.38 0.29 0.27

Apollomics  (NAS:APLMW) Long-Term Capital Lease Obligation Explanation

Long-Term Capital Lease Obligation are the amount due for long-term asset lease agreements that are nearly equivalent to asset purchases. Capital lease obligations are installment payments that constitute a payment of principal plus interest for the capital lease. The Short-Term Capital Lease Obligation is the portion of a Long-Term Capital Lease Obligation that is due over the next year.

Under US Generally Accepted Accounting Principles (GAAP), a capital lease is essentially equivalent to a purchase by the lessee if it meets the following criteria:

1. Ownership of the asset is transferred to the lessee at the end of the lease term;
2. The lease contains a bargain purchase option to buy the equipment at less than fair market value;
3. The lease term equals or exceeds 75% of the asset's estimated useful life;
4. The present value of the lease payments equals or exceeds 90% of the total original cost of the equipment.

Apollomics Long-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Apollomics's Long-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Apollomics (Apollomics) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Apollomics Inc (NAS:APLMW) » Definitions » Long-Term Capital Lease Obligation
Comparable Companies
ATHA STTK ACXP CARA TLSA ORMP IMMX CCCC GTHX GBIO OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX
Traded in Other Exchanges
APLM:USA
Address
989 East Hillsdale Boulevard, Suite 220, Foster, CA, USA, 94404
Website
https://www.apollomicsinc.com
Apollomics Inc is an innovative clinical-stage biotechnology company. It is is focused on the discovery and development of oncology therapies with the potential to be combined with other treatment options to harness the immune system and target specific molecular pathways to inhibit cancer. It has a pipeline of 9 drug candidates across multiple programs, 6 of which are in the clinical stage of development.